Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis

Healthcare expenditure on pharmaceuticals, especially innovative oncology drugs, is escalating. Current knowledge on this topic is largely limited to studies conducted upon reimbursement of new drugs. We investigated how endogenous factors (e.g., changed reimbursement criteria, such as an expanded i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Kai‐Hsin, Ko, Bor‐Sheng, Chen, Liang‐Kung, Hsiao, Fei‐Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719368/
https://www.ncbi.nlm.nih.gov/pubmed/32583962
http://dx.doi.org/10.1111/cts.12829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719368/
https://www.ncbi.nlm.nih.gov/pubmed/32583962
http://dx.doi.org/10.1111/cts.12829

Ejemplares similares